Skip to main content

Comparison of Intrathecal Dotarizine and Nimodipine Treatments in Cerebral Vasospasm After Subarachnoid Hemorrhage: An Experimental Study in Rabbits

  • Conference paper
Early Brain Injury or Cerebral Vasospasm

Part of the book series: Acta Neurochirurgica Supplements ((NEUROCHIRURGICA,volume 110/2))

  • 1125 Accesses

Abstract

Background: Cerebral vasospasm (CVS) is one of the most considerable complications of subarachnoid hemorrhage (SAH). The aim of this study was to assess and to compare the ability of intrathecal dotarizine and nimodipine to prevent and treat vasospasm in a rabbit model of subarachnoid hemorrhage.

Method: Thirty male New Zealand white rabbits weighing 2,500–3,000 g were allocated into five groups randomly. The treatment groups were as follows: Control, only SAH, SAH/Dotarizine, SAH/Nimodipine, SAH/Vehicle. Forty-eight hours after SAH injection, all animals underwent femoral artery catheterization procedure by open surgery under anesthesia and angiography performed for each animal in the fifth day just before sacrifice.

Findings: Basilar artery vessel diameters are measured by angiography. Basilar artery vessel diameters and luminal sectional areas are measured in pathology slides. There was a statistically significant difference between the mean basilar artery cross-sectional areas and the mean arterial wall thickness measurements of the control and SAH-only groups (p < 0.05).

Conclusions: These findings demonstrate that calcium channel blocker dotarizine has marked vasodilatory effect in an experimental model of SAH in rabbits. Nimodipine is an effect-proven agent in CVS, but dotarizine may take place of it.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Conti A, Angileri FF, Longo M, Pitrone A, Granata F, La Rosa G. Intra-arterial nimodipine to treat symptomatic cerebral vasospasm following traumatic subarachnoid haemorrhage. Technical case report. Acta Neurochir (Wien). 2008;150(11):1197–202.

    Article  Google Scholar 

  2. Dorhout Mees SM, Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M,et al. Calcium antagonists for aneurysmal subarachnoid hemorrhage. Stroke. 2008;39:514.

    Article  Google Scholar 

  3. Firat MM, Gelebek V, Orer HS, Belen D, Firat AK, Balkanci F. Selective intraarterial nimodipine treatment in an experimental subarachnoid hemorrhage model. AJNR. 2005;26(6):1357–62.

    PubMed  Google Scholar 

  4. Koèniewska E, Michalik R, Rafalowska J, Gadamski R, Walski M, Frontczak-baniewicz M, et al. Mechanisms of vascular dysfunction after subarachnoid hemorrhage. J Physiol Pharmacol. 2006;57 Suppl 11:145.

    Google Scholar 

  5. Komotar RJ, Zacharia BE, Valhora R, Mocco J, Sander Connolly E Jr. Advances in vasospasm treatment and prevention J Neur Sci. 2007;261:134–142.

    Article  CAS  Google Scholar 

  6. Kuridze N, Czernickia Z, Dziedzic KJ, Jurkiewicz J, Navarro JC. Regional differences of cerebrovascular reactivity effected by calcium channel blocker Dotarizine J Neuro Sci. 2000;175:13–16.

    Article  CAS  Google Scholar 

  7. Mayer TE, Dichgans M, Straube A, Birnbaum T, Müller-Schunk S, Hamann GF, et al. Continuous intra-arterial nimodipine for the treatment of cerebral vasospasm.Cardiovasc Intervent Radiol. 2008;31(6):1200–4.

    Article  PubMed  Google Scholar 

  8. Olivera BM, Miljanich GP, Ramachandran J, Adams ME. Calcium channel diversity and neurotransmitter release: the omega-conotoxins and omega-agatoxins. Annu Rev Biochem. 1994;63:823–67.

    Article  PubMed  CAS  Google Scholar 

  9. Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ. 1989;298:636–42.

    Article  PubMed  CAS  Google Scholar 

  10. Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2005;25;(1):CD000277.

    Google Scholar 

  11. Tejerina T, Chulia T, Gonzalez P. Effects of dotarizine on 45Ca2+ movements and contractile responses in vascular smooth muscle. Eur J Pharmacol. 1993;239(1–3):75–81.

    Article  PubMed  CAS  Google Scholar 

  12. Treggiari-Venzi MM, Suter PM, Romand JA. Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrhage: a problem of neurointensive care. Neurosurgery. 2001;48(2):249–61.

    PubMed  CAS  Google Scholar 

  13. Villarroya M, Gandía L, Lara B, Albillos A, López MG, García AG. Dotarizine versus flunarizine as calcium antagonists in chromaffin cells. Br J Pharmacol. 1995;114(2):369–76.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mehmet Bulent Onal .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag/Wien

About this paper

Cite this paper

Onal, M.B. et al. (2011). Comparison of Intrathecal Dotarizine and Nimodipine Treatments in Cerebral Vasospasm After Subarachnoid Hemorrhage: An Experimental Study in Rabbits. In: Feng, H., Mao, Y., Zhang, J.H. (eds) Early Brain Injury or Cerebral Vasospasm. Acta Neurochirurgica Supplements, vol 110/2. Springer, Vienna. https://doi.org/10.1007/978-3-7091-0356-2_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-0356-2_11

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-0355-5

  • Online ISBN: 978-3-7091-0356-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics